Identifying and supporting overdose responders to improve prevention efforts
Official title: A network-based, mixed methods study to identify and support multiple overdose responders and inform overdose prevention interventions
Funded at University of Nevada Reno · NIH-10590120 · Data updated 2026-11-12
This study is looking at how to make overdose education and naloxone distribution better for people who use drugs in Reno, Nevada, by understanding why some people help during overdoses while others don’t, so we can find ways to support those who do and improve the community's response to overdoses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nevada Reno NIH-funded |
| Lab location | 1 site (Reno, United States) |
| Project start | September 30, 2022 |
| Project end | September 29, 2025 |
| Funding year | 2022 |
| Award (this year) | $2,034,699 |
| NIH project number | 1R01DA057682-01 |
| Project ID | NIH-10590120 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who use drugs and are either actively involved in responding to overdoses or are interested in learning how to do so.
✕Less likely to help
Patients who do not use drugs or are not involved in overdose response may not benefit from this research.
What this research studies
This research investigates how to enhance overdose education and naloxone distribution programs for people who use drugs (PWUD). It aims to understand why some individuals actively respond to overdoses while others do not, focusing on individual characteristics, social networks, and contextual factors. By recruiting 300 PWUDs in Reno, Nevada, the study will gather both quantitative and qualitative data to identify the support needed for those who frequently respond to overdoses and to improve overall community response capabilities.
Why it matters
Potential benefit: If successful, this research could lead to more effective overdose prevention strategies and better support systems for individuals who respond to overdoses.
How similar studies have gone: Previous research has shown that community-based interventions can effectively improve overdose response rates, suggesting that this approach may yield valuable insights.
Where this research is happening
-
University of Nevada Reno
Reno, United States Active
Researchers
- Principal investigator: Wagner, Karla D. — University of Nevada Reno
- Study coordinator: Wagner, Karla D.
Related research
Other NIH-funded projects on the same topics.
-
How PrEP Drugs Affect HIV Risk in Women and Reproductive Health
This project looks at how PrEP medicines work for women, and whether they influence pregnancy-related processes in the uterus.
-
TrkB’s role in SCI-related bladder cell death and overactivity
Researchers are studying how a brain-derived nerve receptor (TrkB) on specific bladder cells may die after spinal cord injury, contributing to urge to urinate problems, to find ways to prevent it.
-
Gut-resident macrophages and gastric function in gastroparesis
A study in people with gastroparesis to understand how gut macrophages affect stomach movement and gut barrier health, with the hope of finding new ways to treat the condition.
-
Molecular details of AKAP signaling and how it directs cell behavior
A clinician-friendly look at how AKAP proteins organize cell signaling to influence disease-related cell functions and how new targeted approaches might control these signals.
-
Role of purinergic signaling in diabetic bladder dysfunction
A study in mouse models of type 2 diabetes will explore how purinergic signaling in the bladder lining may contribute to bladder dysfunction.
-
Fixing cholesterol transport to restore nerve insulation in inherited peripheral neuropathies
This project aims to boost the ABCA1 cholesterol transporter to help restore myelin (the insulating layer around nerves) in people with inherited peripheral demyelinating neuropathies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.